JOINT FILING AGREEMENT
Exhibit 99.1
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D dated December 26, 2019 (including amendments thereto) with respect to the shares of Common Stock, $0.001 par value per share, of Five Prime Therapeutics, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: December 26, 2019
| BIOTECHNOLOGY VALUE FUND, L.P. | BVF INC. | |||
| By: | BVF Partners L.P., its general partner | By: | /s/ Xxxx X. Xxxxxxx | |
| By: | BVF Inc., its general partner | Xxxx X. Xxxxxxx | ||
| President | ||||
| By: |
/s/ Xxxx X. Xxxxxxx |
|||
| Xxxx X. Xxxxxxx | ||||
| President | /s/ Xxxx X. Xxxxxxx | |||
| XXXX X. XXXXXXX | ||||
| BIOTECHNOLOGY VALUE FUND II, L.P. | ||||
| By: | BVF Partners L.P., its general partner | |||
| By: | BVF Inc., its general partner | |||
| By: |
/s/ Xxxx X. Xxxxxxx |
|||
| Xxxx X. Xxxxxxx | ||||
| President | ||||
| BVF PARTNERS L.P. | ||||
| By: | BVF Inc., its general partner | |||
| By: |
/s/ Xxxx X. Xxxxxxx |
|||
| Xxxx X. Xxxxxxx | ||||
| President | ||||
| BVF PARTNERS OS LTD. | ||||
| By: | BVF Partners L.P., its sole member | |||
| By: | BVF Inc., its general partner | |||
| By: |
/s/ Xxxx X. Xxxxxxx |
|||
| Xxxx X. Xxxxxxx | ||||
| President | ||||
| Biotechnology Value Trading Fund OS LP | ||
| By: | BVF Partners L.P., its investment manager | |
| By: | BVF Inc., its general partner | |
| By: |
/s/ Xxxx X. Xxxxxxx |
|
| Xxxx X. Xxxxxxx | ||
| President | ||
